南華生物(000504.SZ):與騰訊雲就合作建設湖南省“博愛基層公衞援建計劃”開展廣泛合作
格隆匯9月28日丨南華生物(000504.SZ)公佈,公司控股子公司南華和平醫院管理(湖南)有限公司(簡稱“南華和平”)於2021年9月27日收到了南華和平與騰訊雲計算(長沙)有限責任公司(簡稱“騰訊雲”)簽訂的《湖南省博愛基層公衞援建計劃戰略合作協議》,雙方同意就合作建設湖南省“博愛基層公衞援建計劃”開展廣泛合作。
雙方將在衞生健康、醫保管理、體育健康、城市健康應急管理、健康科技金融、醫療健康產業等領域開展合作:依託基層公衞數字健康平台,服務民生需求;依託數字化醫療管理系統,聚焦醫療價值,優化工作流程;依託互聯網+等技術手段,助力政府智能監管決策降本增效,提升社會治理能力;引進聚集騰訊投後企業和產業鏈上下游企業,促進數字健康產業發展,釋放數字經濟紅利、促進產業轉型升級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.